(Q81276843)
Statements
HER-2/neu assessment in breast cancer using the original FDA and new ASCO/CAP guideline recommendations: impact on selecting patients for herceptin therapy (English)
Matteo Brunelli
Guido Martignoni
Samantha Bersani
Daniela Reghellin
Marco Chilosi
Franco Bonetti